Also known as: Lopidine

Therapeutic indications

Apraclonidine is indicated for:

Chronic glaucoma

Population group: both men and women, only adults (18 years old or older)

Apraclonidine is indicated for short-term adjunctive therapy of chronic glaucoma in patients on maximally tolerated medical therapy who require additional intraocular pressure (IOP) reduction to delay laser treatment or glaucoma surgery.

For this indication, competent medicine agencies globally authorize below treatments (click for details):


Apraclonidine is contraindicated in the following cases:

Monoamine oxidase inhibitors

Monoamine oxidase inhibitors (MAOIs)

Tricyclic antidepressants

Systemic sympathomimetics

at least one of
Sympathomimetics, plain


Sympathomimetic amines

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines